Cullinan Therapeutics (CGEM) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist

9.530
-0.060-0.63%

Close Feb 14 16:00 ET

554.91MMarket Cap-3.36P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cullinan Therapeutics (NASDAQ:CGEM) Is In A Good Position To Deliver On Growth Plans
Yahoo FinanceJan 31 09:46 ET
A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $29 to $36
Moomoo NewsJan 30 08:00 ET · Ratings
Cullinan Therapeutics to Participate in Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
GlobeNewswireJan 30 07:00 ET
Cullinan Oncology Is Maintained at Buy by HC Wainwright & Co.
Dow JonesJan 29 13:09 ET · Ratings
HC Wainwright & Co. Maintains Buy on Cullinan Therapeutics, Raises Price Target to $33
BenzingaJan 29 12:59 ET · Ratings
Cullinan Therapeutics Analyst Ratings
BenzingaJan 29 12:57 ET · Ratings

Comments

Jaguar8

Oct 16, 2024 06:38

NEWS

$Cullinan Therapeutics (CGEM.US)$
Cullinan Therapeutics Receives U.S. FDA Clearance of Investigational New Drug Application for CLN-978 Administered Subcutaneously in Patients with Moderate to Severe Systemic Lupus Erythematosus
Cullinan Therapeutics (Nasdaq: CGEM) announced FDA clearance of its Investigational New Drug (IND) Application for CLN-978, allowing its global Phase 1 clinical trial to proceed in the U.S. for patients with moderate to severe systemic lupus erythematosus (SLE). CLN-9...

Jaguar8

Apr 24, 2024 09:10

$Cullinan Therapeutics (CGEM.US)$
NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

Moomoo Breakfast US

May 12, 2022 07:18

Columns Today's pre-market stock movers: BYND, DIS, F, GM and more

Gainers:
• $Cullinan Therapeutics (CGEM.US)$ +22.4% (Cullinan Management and Taiho Pharmaceutical to collaborate to jointly develop and commercialize CLN081/TAS6417 and Taiho's acquisition of Cullinan Pearl)
• $Lordstown Motors (RIDE.US)$ +17.2% (closes asset purchase agreement with Foxconn)
• $Applovin (APP.US)$ +15.5%(In reaction to earnings)
• $SmartRent (SMRT.US)$ +15.4%(In reaction to earnings)
• $Coupang (CPNG.US)$ +14.3%(In reaction to earn...

OldNormanBates

Jan 6, 2021 05:38

$Cullinan Therapeutics (CGEM.US)$ ISO this week in Biotech Pharma.

CGEM Cullinan Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks